查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1451033

2024-2032 年按药物类别、适应症、配销通路和地区分類的疼痛管理药物市场报告

Pain Management Drugs Market Report by Drug Class, Indication, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3个工作天内

价格

2023年，全球疼痛管理药物市场规模达到697亿美元。展望未来， IMARC Group预计到2032年市场规模将达到872亿美元，2024-2032年复合年增长率（CAGR）为2.4%。由于慢性病盛行率不断上升、疼痛管理疗法的快速进步、疼痛管理意识和教育的提高、支持性政府和监管框架的实施以及对有效术后疼痛管理的需求不断增长，市场正在经历强劲增长。

疼痛管理药物市场分析：

市场成长与规模：在慢性病盛行率不断上升、疼痛管理疗法快速进步以及对有效和更安全的疼痛缓解方案的需求不断增长的推动下，市场正在稳定成长。

主要市场驱动因素：影响市场成长的主要驱动因素包括关节炎和癌症发病率上升、药物开发技术的快速进步、疼痛管理意识和教育的提高以及政府支持政策的实施。

主要市场趋势：主要市场趋势涉及在全球阿片类药物危机和对更安全的疼痛管理方案的需求的推动下，不断转向非阿片类药物的开发。此外，人们越来越关注个人化医疗和药物基因组学，以提供更有针对性和更有效的疼痛管理策略，这也促进了市场的成长。

地理趋势：由于先进的医疗保健系统、慢性疼痛的高盛行率以及不断努力开发替代性疼痛管理疗法，北美在市场上处于领先地位。在医疗基础设施增加、慢性病盛行率上升和製药业扩张的推动下，其他地区也出现了显着成长。

竞争格局：市场的特点是主要参与者积极参与，他们参与研发（R＆D）、合作和併购等策略性倡议，以增强其市场地位。此外，该公司还专注于创新并扩展其产品组合，以包括新颖且有效的疼痛管理解决方案。

挑战与机会：市场面临各种挑战，例如需要平衡阿片类药物使用的功效与安全性以及应对复杂的监管环境。然而，新治疗领域的发展以及对个人化疼痛管理方法的日益关注，正在为市场成长创造新的机会。

疼痛管理药物市场趋势：

慢性病盛行率增加

关节炎、癌症、糖尿病和心臟病等慢性疾病的发生率不断上升，需要使用止痛药物，这是推动市场成长的主要因素之一。此外，越来越多地使用疼痛管理药物来改善患者的生活质量，这也是一种生长诱导因素。此外，全球不断增长的易患骨关节炎和神经性疼痛等慢性病的老年人口正在放大市场的成长。除此之外，生活方式的不断变化导致肥胖和缺乏身体活动等风险因素增加，正在推动市场成长。此外，慢性病疼痛日益复杂，需要采用多模式方法进行疼痛管理，这正在扩大市场的成长。

疼痛管理疗法的快速进步

疼痛管理技术的快速进步，导致了新的、更有效的药物（包括生物製剂和标靶治疗）的开发，为市场成长创造了积极的前景。与此一致的是，减少传统疼痛治疗药物副作用的治疗功效不断提高，有利于市场成长。此外，製药业对研发 (R&D) 的日益关注，导致推出具有更好疼痛管理特性的药物，为市场成长创造了积极的前景。此外，个人化医疗和药物基因组学的日益普及，可以实现更有针对性和更有效的疼痛管理策略，预计将推动市场成长。

对疼痛管理的认识不断增强

医疗保健专业人员和患者对疼痛管理的认识和教育不断提高是推动市场成长的主要因素。此外，有能力开出适当疼痛管理药物的医疗保健提供者的理解和培训的不断加深，也促进了市场的成长。同时，越来越多的患者了解药物的好处和影响，促使他们寻求治疗疼痛的方法，从而推动了市场的成长。除此之外，政府和医疗机构实施的各种宣传活动和教育计画也是促进成长的因素。与此一致的是，推出了多项专注于纤维肌痛和神经性疼痛等慢性疼痛疾病管理的倡议，以提高人们对这些疾病和可用治疗方案的认识，这对市场成长产生了积极影响。

不断增加的政府和监管支持

支持新药开发和批准的各种政府措施和政策的实施正在为市场成长创造积极的前景。据此，孤儿药开发快速审批和激励措施的引入，鼓励製药公司投资新的疼痛管理疗法，预计将推动市场成长。此外，政府资助的医疗保健计划和报销政策的实施直接影响疼痛管理药物的可近性和可负担性，为市场成长提供了相当大的推动力。此外，越来越多的计画旨在增加服务不足地区获得疼痛管理药物的机会，并认识到疼痛管理是公共卫生的关键组成部分，正在促进市场成长。同时，对新型疼痛管理疗法研究的资助和补助金不断增加，鼓励创新和发展，这为市场成长提供了动力。

增加外科手术和术后疼痛管理

全球外科手术的不断增加，推动了对疼痛管理药物的需求，从而推动了市场的成长。此外，广泛使用术后疼痛管理来促进患者復健正在推动市场成长。除此之外，选择性和微创（MI）外科手术的日益普及，导致对有效疼痛管理药物的需求相应增加，预计将推动市场成长。外科手术会导致急性疼痛，需要进行管理以促进患者康復并预防併发症。除此之外，有效的术后疼痛管理可以提高患者的舒适度，并降低血栓形成、肺部问题和慢性疼痛综合征等术后併发症的风险。除此之外，医院对加速復健外科（ERAS）方案的日益重视，凸显了有效疼痛管理策略的重要性，正在为市场创造积极的前景。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球疼痛管理药物市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场区隔：依药品类别
  • 市场区隔：依指标
  • 市场区隔：按配销通路
  • 市场区隔：按地区
  • 市场预测

第 6 章：市场区隔：依药物类别

  • 非类固醇抗发炎药
    • 市场走向
    • 市场预测
  • 麻醉剂
    • 市场走向
    • 市场预测
  • 抗惊厥药
    • 市场走向
    • 市场预测
  • 抗偏头痛剂
    • 市场走向
    • 市场预测
  • 抗忧郁药
    • 市场走向
    • 市场预测
  • 阿片类药物
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依迹象

  • 肌肉骨骼疼痛
    • 市场走向
    • 市场预测
  • 手术和创伤疼痛
    • 市场走向
    • 市场预测
  • 癌症痛
    • 市场走向
    • 市场预测
  • 神经性疼痛
    • 市场走向
    • 市场预测
  • 偏头痛
    • 市场走向
    • 市场预测
  • 产科疼痛
    • 市场走向
    • 市场预测
  • 纤维肌痛
    • 市场走向
    • 市场预测
  • 烧伤痛
    • 市场走向
    • 市场预测
  • 牙齿/脸部疼痛
    • 市场走向
    • 市场预测
  • 小儿疼痛
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按配销通路

  • 医院药房
    • 市场走向
    • 市场预测
  • 零售药局
    • 市场走向
    • 市场预测
  • 网路药局
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 市场走向
    • 市场预测
  • 欧洲
    • 市场走向
    • 市场预测
  • 亚太地区
    • 市场走向
    • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场预测
  • 拉丁美洲
    • 市场走向
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

  • 价格指标
  • 价格结构
  • 利润分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories, Inc.
    • Pfizer, Inc.
    • Eli Lilly & Company
    • Endo International plc
    • F. Hoffmann-La Roche AG
    • Bausch Health Companies, Inc.
    • Merck & Co. Inc.
    • Allergen Inc.
    • Novartis International AG
    • Johnson & Johnson Private Limited
    • GlaxoSmithKline Plc
    • Purdue Pharma LP
Product Code: SR112024A1330

The global pain management drugs market size reached US$ 69.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 87.2 Billion by 2032, exhibiting a growth rate (CAGR) of 2.4% during 2024-2032. The market is experiencing robust growth driven by the increasing prevalence of chronic diseases, rapid advancements in pain management therapies, heightened awareness and education about pain management, the implementation of supportive government and regulatory frameworks, and the rising demand for effective post-operative pain management.

Pain Management Drugs Market Analysis:

Market Growth and Size: The market is witnessing stable growth, driven by the increasing prevalence of chronic diseases, rapid advancements in pain management therapies, and the growing demand for effective and safer pain relief options.

Major Market Drivers: Key drivers influencing the market growth include the rising incidence of arthritis and cancer, rapid technological advancements in drug development, increasing awareness and education about pain management, and the implementation of supportive government policies.

Key Market Trends: The key market trends involve the ongoing shift towards the development of non-opioid medications, driven by the global opioid crisis and the need for safer pain management options. Additionally, the increasing focus on personalized medicine and pharmacogenomics that offer more targeted and effective pain management strategies, is bolstering the market growth.

Geographical Trends: North America leads the market due to advanced healthcare systems, high prevalence of chronic pain, and ongoing efforts to develop alternative pain management therapies. Other regions are also showing significant growth, fueled by increasing healthcare infrastructure, rising chronic disease prevalence, and expanding pharmaceutical sectors.

Competitive Landscape: The market is characterized by the active involvement of key players who are engaged in strategic initiatives such as research and development (R&D), collaborations, and mergers and acquisitions to enhance their market position. Furthermore, companies are focusing on innovation and expanding their product portfolios to include novel and effective pain management solutions.

Challenges and Opportunities: The market faces various challenges, such as the need for balancing efficacy with safety in opioid use and navigating complex regulatory environments. However, the development of new therapeutic areas, and growing focus on personalized pain management approaches, are creating new opportunities for the market growth.

Pain Management Drugs Market Trends:

Increasing prevalence of chronic diseases

The rising incidence of chronic diseases, such as arthritis, cancer, diabetes, and heart disease, necessitating the use of pain management drugs, is one of the major factors boosting the market growth. Moreover, the increasing utilization of pain management drugs to improve the quality of life of patients, is acting as a growth-inducing factor. Additionally, the growing geriatric population across the globe who are susceptible to chronic conditions, such as osteoarthritis and neuropathic pain, is amplifying the market growth. In addition to this, the rising lifestyle changes, leading to an increase in risk factors, like obesity and physical inactivity, is driving the market growth. Furthermore, the increasing complexity of pain in chronic diseases requiring a multimodal approach to pain management is expanding the market growth.

Rapid advancements in pain management therapies

The rapid technological advancements in pain management, leading to the development of new and more effective drugs, including biologics and targeted therapies, is creating a positive outlook for the market growth. In line with this, the rising improvements in the efficacy of treatments to reduce side effects associated with traditional pain management drugs, is favoring the market growth. Additionally, the increasing focus by the pharmaceutical industry on research and development (R&D), leading to the introduction of drugs with better pain management profiles, is creating a positive outlook for the market growth. Additionally, the rising popularity of personalized medicine and pharmacogenomics that enable more targeted and effective pain management strategies, is anticipated to drive the market growth.

Growing awareness about pain management

The increasing awareness and education about pain management among healthcare professionals and patients is a major factor propelling the market growth. Moreover, the rising understanding and training among healthcare providers who are equipped to prescribe appropriate pain management drugs, is contributing to the market growth. Along with this, the growing education among patients about the benefits and implications of drugs, prompting them to seek treatment for their pain, is boosting the market growth. Besides this, the implementation of various awareness campaigns and educational programs by governments and healthcare organizations is acting as a growth-inducing factor. In line with this, the introduction of several initiatives focusing on the management of chronic pain conditions, like fibromyalgia and neuropathic pain to increase awareness about the conditions and the available treatment options, is positively influencing the market growth.

Rising government and regulatory support

The imposition of various government initiatives and policies that support the development and approval of new drugs is creating a positive outlook for the market growth. In line with this, the introduction of fast-track approvals and incentives for orphan drug development that encourage pharmaceutical companies to invest in new pain management therapies, is anticipated to drive the market growth. Furthermore, the implementation of government-funded healthcare programs and reimbursement policies that directly influence the accessibility and affordability of pain management drugs, is providing a considerable boost to the market growth. Additionally, the growing establishment of programs to increase access to pain management drugs in underserved areas, recognizing pain management as a key component of public health, is fostering the market growth. Along with this, the rising initiatives in funding and grants for research in novel pain management therapies, encouraging innovation and development is providing an impetus to the market growth.

Increasing surgical procedures and post-operative pain management

The rising surgical procedures across the globe, driving the demand for pain management drugs is fueling the market growth. Moreover, the widespread utilization of post-operative pain management for patient recovery is boosting the market growth. Besides this, the increasing prevalence of elective and minimally invasive (MI) surgical procedures, leading to a corresponding rise in the demand for effective pain management drugs is anticipated to drive the market growth. Surgical procedures result in acute pain that requires management to facilitate patient recovery and prevent complications. In addition to this, effective post-operative pain management improves patient comfort and reduces the risk of post-surgical complications such as thrombosis, pulmonary issues, and chronic pain syndromes. Apart from this, the growing emphasis on enhanced recovery after surgery (ERAS) protocols in hospitals, highlighting the importance of effective pain management strategies, is creating a positive outlook for the market.

Pain Management Drugs Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global and regional levels for 2024-2032. Our report has categorized the market based on drug class, indication, and distribution channel.

Breakup by Drug Class:

NSAIDs

Anesthetics

Anticonvulsants

Antimigraine Agents

Antidepressants

Opioids

Others

Opioids accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the drug class. This includes NSAIDs, anesthetics, anticonvulsants, antimigraine agents, antidepressants, opioids, and others. According to the report, opioids represented the largest segment.

Breakup by Indication:

Musculoskeletal Pain

Surgical and Trauma Pain

Cancer Pain

Neuropathic Pain

Migraine Pain

Obstetrical Pain

Fibromyalgia Pain

Burn Pain

Dental/Facial Pain

Pediatric Pain

Others

Musculoskeletal pain holds the largest share in the industry

A detailed breakup and analysis of the market based on the indication have also been provided in the report. This includes musculoskeletal pain, surgical and trauma pain, cancer pain, neuropathic pain, migraine pain, obstetrical pain, fibromyalgia pain, burn pain, dental/facial pain, pediatric pain, and others. According to the report, musculoskeletal pain accounted for the largest market share.

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Hospital pharmacies represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the distribution channel. This includes hospital pharmacies, retail pharmacies, and online pharmacies. According to the report, hospital pharmacies represented the largest segment.

Breakup by Region:

North America

Europe

Asia Pacific

Middle East and Africa

Latin America

North America leads the market, accounting for the largest pain management drugs market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America accounted for the largest market share.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories, Inc.

Pfizer, Inc.

Eli Lilly & Company

Endo International plc

F. Hoffmann-La Roche AG

Bausch Health Companies, Inc.

Merck & Co. Inc.

Allergen Inc.

Novartis International AG

Johnson & Johnson Private Limited

GlaxoSmithKline Plc

Purdue Pharma L.P.

Key Questions Answered in This Report

  • 1. What was the global pain management drugs market size in 2023?
  • 2. How will the global pain management drugs market perform over the next five years 2024-2032?
  • 3. What is the impact of COVID-19 on the global pain management drugs market?
  • 4. What are the key global pain management drugs market drivers?
  • 5. What are the major trends in the global pain management drugs market?
  • 6. What is the leading drug class in the global pain management drugs market?
  • 7. What is the major indication in the global pain management drugs market?
  • 8. What is the global pain management drugs market breakup by distribution channel?
  • 9. What are the major regions in the global pain management drugs market?
  • 10. Who are the leading pain management drug manufacturers?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pain Management Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Drug Class
  • 5.5 Market Breakup by Indication
  • 5.6 Market Breakup by Distribution Channel
  • 5.7 Market Breakup by Region
  • 5.8 Market Forecast

6 Market Breakup by Drug Class

  • 6.1 NSAIDs
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Anesthetics
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Anticonvulsants
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Antimigraine Agents
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Antidepressants
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Opioids
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Musculoskeletal Pain
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Surgical and Trauma Pain
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cancer Pain
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Neuropathic Pain
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Migraine Pain
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Obstetrical Pain
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Fibromyalgia Pain
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Burn Pain
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast
  • 7.9 Dental/Facial Pain
    • 7.9.1 Market Trends
    • 7.9.2 Market Forecast
  • 7.10 Pediatric Pain
    • 7.10.1 Market Trends
    • 7.10.2 Market Forecast
  • 7.11 Others
    • 7.11.1 Market Trends
    • 7.11.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Europe
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Asia Pacific
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Middle East and Africa
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Latin America
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

  • 13.1 Price Indicators
  • 13.2 Price Structure
  • 13.3 Margin Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories, Inc.
    • 14.3.2 Pfizer, Inc.
    • 14.3.3 Eli Lilly & Company
    • 14.3.4 Endo International plc
    • 14.3.5 F. Hoffmann-La Roche AG
    • 14.3.6 Bausch Health Companies, Inc.
    • 14.3.7 Merck & Co. Inc.
    • 14.3.8 Allergen Inc.
    • 14.3.9 Novartis International AG
    • 14.3.10 Johnson & Johnson Private Limited
    • 14.3.11 GlaxoSmithKline Plc
    • 14.3.12 Purdue Pharma L.P

List of Figures

  • Figure 1: Global: Pain Management Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Pain Management Drugs Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Pain Management Drugs Market: Breakup by Drug Class (in %), 2023
  • Figure 4: Global: Pain Management Drugs Market: Breakup by Indication (in %), 2023
  • Figure 5: Global: Pain Management Drugs Market: Breakup by Distribution Channel (in %), 2023
  • Figure 6: Global: Pain Management Drugs Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Pain Management Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 8: Global: Pain Management Drugs Industry: SWOT Analysis
  • Figure 9: Global: Pain Management Drugs Industry: Value Chain Analysis
  • Figure 10: Global: Pain Management Drugs Industry: Porter's Five Forces Analysis
  • Figure 11: Global: Pain Management Drugs (NSAIDs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Pain Management Drugs (NSAIDs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Pain Management Drugs (Anesthetics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Pain Management Drugs (Anesthetics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Pain Management Drugs (Anticonvulsants) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Pain Management Drugs (Anticonvulsants) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Pain Management Drugs (Antimigraine Agents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Pain Management Drugs (Antimigraine Agents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Pain Management Drugs (Antidepressants) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Pain Management Drugs (Antidepressants) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Pain Management Drugs (Opioids) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Pain Management Drugs (Opioids) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Pain Management Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Pain Management Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Pain Management Drugs (Musculoskeletal Pain) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Pain Management Drugs (Musculoskeletal Pain) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Pain Management Drugs (Surgical and Trauma Pain) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Pain Management Drugs (Surgical and Trauma Pain) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Pain Management Drugs (Cancer Pain) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Pain Management Drugs (Cancer Pain) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Pain Management Drugs (Neuropathic Pain) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Pain Management Drugs (Neuropathic Pain) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Pain Management Drugs (Migraine Pain) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Pain Management Drugs (Migraine Pain) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Pain Management Drugs (Obstetrical Pain) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Pain Management Drugs (Obstetrical Pain) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Pain Management Drugs (Fibromyalgia Pain) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Pain Management Drugs (Fibromyalgia Pain) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Pain Management Drugs (Burn Pain) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Pain Management Drugs (Burn Pain) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Pain Management Drugs (Dental/Facial Pain) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Pain Management Drugs (Dental/Facial Pain) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Global: Pain Management Drugs (Pediatric Pain) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Global: Pain Management Drugs (Pediatric Pain) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Global: Pain Management Drugs (Other Indications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Global: Pain Management Drugs (Other Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Global: Pain Management Drugs Market: Sales through Hospital Pharmacies (in Million US$), 2018 & 2023
  • Figure 48: Global: Pain Management Drugs Market Forecast: Sales through Hospital Pharmacies (in Million US$), 2024-2032
  • Figure 49: Global: Pain Management Drugs Market: Sales through Retail Pharmacies (in Million US$), 2018 & 2023
  • Figure 50: Global: Pain Management Drugs Market Forecast: Sales through Retail Pharmacies (in Million US$), 2024-2032
  • Figure 51: Global: Pain Management Drugs Market: Sales through Online Pharmacies (in Million US$), 2018 & 2023
  • Figure 52: Global: Pain Management Drugs Market Forecast: Sales through Online Pharmacies (in Million US$), 2024-2032
  • Figure 53: North America: Pain Management Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: North America: Pain Management Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Europe: Pain Management Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Europe: Pain Management Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Asia Pacific: Pain Management Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Asia Pacific: Pain Management Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Middle East and Africa: Pain Management Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Middle East and Africa: Pain Management Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Latin America: Pain Management Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Latin America: Pain Management Drugs Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

  • Table 1: Global: Pain Management Drugs Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Pain Management Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
  • Table 3: Global: Pain Management Drugs Market Forecast: Breakup by Indication (in Million US$), 2024-2032
  • Table 4: Global: Pain Management Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Pain Management Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Pain Management Drugs Market Structure
  • Table 7: Global: Pain Management Drugs Market: Key Players